ArticleFrontiers in oncology2026

Efficacy and safety of chemotherapy plus immunotherapy in unresectable stage III-IV non-small cell lung cancer, with analysis of the additional role of anti-angiogenic agents.

Xifen Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.